4.1 Interventions to raise haemoglobin levels in patients with malignancies
Background question 1
In patients with malignancies (solid tumours) undergoing radiotherapy, do interventions (transfusion or ESAs) aimed at raising the Hb concentration during radiotherapy affect patient outcomes (e.g. response rate, tumour recurrence or tumour-free survival)?
ESA, erythropoiesis-stimulating agent; Hb, haemoglobin